Screener
OptimizeRx OPRX Total Revenue
Discontinued — last reported Q2 '26
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: OptimizeRx’s 10-Q, filed August 13, 2026.
- Filed
- Aug 13, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001448431-26-000016
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net revenue | $20,504 | $29,195 | $40,348 | $51,123 |
| Expenses | ||||
| Cost of revenues, exclusive of depreciation and amortization presented separately below | 4,816 | 10,560 | 9,728 | 19,144 |
| Sales and marketing | 5,528 | 5,865 | 10,257 | 10,850 |
| General and administrative | 3,702 | 3,909 | 7,215 | 8,466 |
| Research and development | 3,274 | 3,092 | 6,676 | 6,344 |
| Stock-based compensation | 2,208 | 1,488 | 4,036 | 3,046 |
| Depreciation and amortization | 1,064 | 1,074 | 2,128 | 2,168 |
Item 1. Financial Statements
FAQ
- What is OptimizeRx's total revenue?
- OptimizeRx (OPRX) reported total revenue of $20.5M in Q2 2026.
- How has OptimizeRx's total revenue changed year-over-year?
- OptimizeRx's total revenue decreased by 29.8% year-over-year, from $29.2M to $20.5M.
- What is the long-term trend for OptimizeRx's total revenue?
- Over 4 years (2021 to 2025), OptimizeRx's total revenue has grown at a 15.6% compound annual growth rate (CAGR), from $61.29M to $109.43M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about OptimizeRx's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude